Cargando…
Comments on “Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine” by Fujimori et al., (2021), J Neuroimmunol
Autor principal: | Caravagna, Céline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598345/ https://www.ncbi.nlm.nih.gov/pubmed/34826735 http://dx.doi.org/10.1016/j.jneuroim.2021.577780 |
Ejemplares similares
-
Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023) -
Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023) -
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
por: Havla, Joachim, et al.
Publicado: (2021) -
Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
por: Fujimori, Juichi, et al.
Publicado: (2021) -
“Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine”: comment
por: Sookaromdee, Pathum, et al.
Publicado: (2022)